| Outcome Measures: |
Primary: Change of glycemia, Assessment of tolerance to insulin resistance measurement technique with 6-DIG scintigraphy, in healthy volunteers * clinical tolerance to 6-DIG infusion * clinical and biological tolerance to insulin infusion * evaluation of dosimetry, Before inclusion in clinical trial, Before radiotracer injection, After radiotracer injection (time: 30s, 1', 2',5',10',15',25', 1 hour, 2 hours, 4 hours, 8 hours, 24 hours) | Secondary: insulinemia, Before inclusion in clinical trial, Before radiotracer injection, After radiotracer injection (time: 30s, 1', 2',5',10',15',25', 1 hour, 2 hours, 4 hours, 8 hours, 24 hours)|clinical side effects, hypoglycemia symptoms, Before inclusion in clinical trial, Before radiotracer injection, After radiotracer injection (time: 30s, 1', 2',5',10',15',25', 1 hour, 2 hours, 4 hours, 8 hours, 24 hours)|dosimetry, organs biodistribution of radioactivity, during the 24 hours following injection of 6-DIG|insulin resistance, scintigraphic measurement of glucose transport in heart before and after infusion of insulin, 0-15 minutes following 6-DIG infusion
|
